ALSUntangled no. 18: apoaequorin (Prevagen).

Authors

Robert Bowser, Barrow Neurological InstituteFollow
ALSUntangled Group

Document Type

Article

Keywords

Aequorin, Amyotrophic Lateral Sclerosis, Apoproteins, Evidence-Based Medicine, Humans, Recombinant Proteins, Treatment Outcome

Medical Subject Headings

Aequorin; Amyotrophic Lateral Sclerosis; Apoproteins; Evidence-Based Medicine; Humans; Recombinant Proteins; Treatment Outcome

Publication Date

1-1-2013

Publication Title

Amyotroph Lateral Scler Frontotemporal Degener

ISSN

2167-9223

Volume

14

Issue

1

First Page

78

Last Page

79

PubMed ID

23030514

Recommended Citation

Bowser, Robert and ALSUntangled Group, "ALSUntangled no. 18: apoaequorin (Prevagen)." (2013). Translational Neuroscience. 1108.
https://scholar.barrowneuro.org/neurobiology/1108